Stay updated on Viatris Press Releases
Sign up to get notified when there's something new on the Viatris Press Releases page.

Latest updates to the Viatris Press Releases page
- Check6 days agoChange DetectedThe press-release list now features three November 2026 announcements covering a global pharmaceutical partnership with the Cadillac Formula 1® Team, workplace recognition, and upcoming investor conferences. Older releases have moved out of the displayed list.SummaryDifference11%

- Check13 days agoChange DetectedThe press release list adds Viatris’s November 5, 2026 third-quarter financial results and drops the July contraceptive-patch approval and second-quarter results announcement. Navigation and footer links are also updated.SummaryDifference13%

- Check20 days agoChange DetectedViatris added a press release announcing a tender offer to acquire Pacira BioSciences. An older release about positive Phase 3 results for VR-205 in Japanese adults with primary IgA nephropathy is no longer shown in the list.SummaryDifference10%

- Check34 days agoChange DetectedThe press release list now features Viatris’ U.S. FDA approval of RYZUMVI for presbyopia, while the earlier announcement that the FDA accepted its meloxicam application for acute pain is no longer displayed.SummaryDifference7%

- Check41 days agoChange DetectedThe press-release list adds Viatris’s October 8, 2026 announcement of an agreement to acquire Pacira BioSciences and its expansion in non-opioid pain therapies, while an older healthcare conference notice is no longer listed.SummaryDifference7%

- Check48 days agoChange DetectedThe release list adds Viatris’s October 5 announcement of its upcoming third-quarter 2026 results and its September 29 recognition by Forbes as a Best Employer. The May 5 first-quarter 2026 results release is no longer listed.SummaryDifference6%

Stay in the know with updates to Viatris Press Releases
Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.